| CBI’s 7th Global Forum on Clinical Trial Registries and Results Databases: Ensure Global Transparency and Manage Clinical Data Disclosure Across Current and Emerging Registries | | Date(s): | April 24 - 25, 2012 |  | | Topic: | Navigate Clinical Trial Disclosure Requirements for Emerging Global Registries | | Location: | Philadelphia, PA | | Presenter: | John McKenney, President, SEC Associates, Inc. | | As the globalization of clinical trial registries and results databases continues to expand, the challenge of reporting and complying with multiple registry requirements becomes ever more difficult. National and regional registries continue to emerge and evolve at a pace that makes it incredibly challenging to stay ahead of the curve. In this session, discover the most recent updates and fine tune your working knowledge of transparency requirements around the globe. • Learn which registries have emerged in the last year • Analyze key requirements across registries • Preview the registries expected to emerge in the months ahead | Click here for more information.
|  |
| DIA 48th Annual Meeting: Collaborate to Innovate | | Date(s): | June 24 - 28, 2012 |  | | Topic: | Hot Topics in Clinical Trial Disclosure (CTD) | | Location: | Philadelphia, PA | | Presenter: | Robert Paarlberg, Principal, Paarlberg & Associates LLC; Merete Joergensen, Director, Global Clinical Registry, Novo Nordisk A/S, Denmark; John McKenney, President, SEC Associates, Inc. | | This showcase will discuss the ever changing clinical trial disclosure (CTD) landscape, the impact on industry, and how companies change their processes to maximize efficiencies to meet the increasing demands of global CTD requirements. Emerging CTD requirements in selected countries will be highlighted. The showcase will also focus on results disclosure in the EU as well as discuss the challenges and complexities companies face in meeting global CTD requirements. An update will be provided on the status of NLM’s Notice of Proposed Rulemaking. In addition, the audience will be encouraged to share their organizations’ perspectives on these issues and how they are meeting the challenges of clinical trial disclosure. Benefits of participating in the SIAC will also be discussed. | Click here for more information.
| Click here to download file information.
| |
|
